EcoDrugPlus

Ensembl ID : ENSJJAG00000014057
Gene Symbol: -
Cross references: -
321 Possible Orthologues:

Ensembl ID : ENSJJAG00000021970
Gene Symbol: -
Cross references: -
5 Possible Orthologues:

Ensembl ID : ENSJJAG00000013958
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSJJAG00000012867
Gene Symbol: -
Cross references: -
399 Possible Orthologues:

Ensembl ID : ENSJJAG00000012164
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSJJAG00000011690
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSJJAG00000010350
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSJJAG00000007388
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSJJAG00000000361
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSJJAG00000000352
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSJJAG00000000210
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSJJAG00000005973
Gene Symbol: -
Cross references: -
485 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).